Ema product license. Apr 16, 2024 · Event summary. However, a small number of patients develop severe disease, with Services and databases. In the Add more licenses pane, select Use a new and unused product key, then select Next. • ≥ 27 kg/m² to < 30 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as dysglycaemia (pre-diabetes Procedural timetables. I am a tenant in a multi-tenanted building and all the tenants in the building have consented to buy electricity en bloc through the landlord/MCST as a contestable consumer collectively. Medicinal products for human use containing a new active substance for which the therapeutic indication is the treatment of any of the following diseases: acquired immune deficiency syndrome (AIDS), cancer, neurodegenerative disorder (like amyotrophic Alzheimer's disease, and Huntington's disease), lateral. The installation of your OrCAD/Allegro 17. Select a radio option to specify access-permissions to the software you are installing. Venclyxto is a cancer medicine used to treat adults with the following blood cancers: chronic lymphocytic leukaemia (CLL). ) Then click the OrCAD product version, such as OrCAD Allegro 17. • ≥ 30 kg/m² (obese), or. Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial Body Mass Index (BMI) of. See how OrCAD X can supercharge your workflow and take your design capabilities to new heights. EMA has recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. Keytruda is mainly used in adults for cancers that are advanced, have spread or returned, are not responding to other treatments or cannot be removed by surgery. Guidelines reflect a harmonised approach of the EU Member States and the Agency on how to interpret and apply the requirements for the demonstration of quality, safety and efficacy set out in the Community directives. Classes of Licensed Electrical Workers A licensed electrical worker (LEW) can design, install, repair, maintain, operate, inspect, and test electrical and supply installations according The European Medicines Agency's scientific guidelines on biological human medicines help applicants prepare marketing authorisation applications. Click the Next button to continue. Shingles is a painful, blistering rash caused by the Dec 22, 2021 · For technical support help contact: techsupport@ema-eda. How to use the defective product report to notify a quality defect to European Medicines Agency; You should receive an acknowledgement in four hours during EMA business hours. This info day provides a comprehensive understanding of Product Management Service (PMS) and its implications on other EMA digital services. Myozyme was withdrawn from the Community register of orphan medicinal products in March 2016 at the end of the 10-year period of market exclusivity. Fee reductions and incentives are available for micro, small and medium-sized enterprises (SMEs), designated orphan medicines, multiple applications on usage patent grounds and other classes of Apr 3, 2024 · The Board is responsible for examining, registering and licensing all emergency medical assistants (EMAs) in B. Venclyxto can be used with obinutuzumab in patients who have not previously been treated for CLL or with Bexsero is a vaccine used to protect individuals from the age of two months against invasive meningococcal disease caused by one group of the bacterium Neisseria meningitidis (group B). View more about OrCAD X Pro and purchase online now! Oct 13, 2023 · Agamree is a medicine for treating Duchenne muscular dystrophy in patients from 4 years of age. Compliance with GDP ensures that: the right products reach the right addressee within a satisfactory time period. The European Medicines Agency (EMA) is responsible for the scientific evaluation of centralised marketing authorisation applications (MAA). As for all medicines, data on the use of Beyfortus are continuously monitored. Product information. The use of this vaccine should be in accordance with official recommendations. Human Regulatory and procedural guidance. The main objective of the EVMPD was to assist the pharmacovigilance activities in the European Economic Area (EEA). Establishment of MRLs. Review and accept the License Agreement. This is aimed at ensuring the quality of data in the XEVMPD on authorised or investigational medicinal products. meningitidis group B. It is also used in children from 6 weeks to 17 years of age to protect Jan 9, 2015 · Lynparza is a cancer medicine used for: continuing treatment after initial treatment of high-grade (fast-growing) cancers of the ovaries, fallopian tubes (which connect the ovaries to the womb), and the peritoneum (membrane lining the abdomen) in: - women whose cancer has come back (relapsed) after previous treatment and in whom platinum-based Your Trusted Source for Complete PCB System Design & Analysis Software. The download process takes several minutes. Select the subscription to which you want to add licenses. OrCAD is built to support you from concept to production and beyond. It can be used in adults who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti CD38 May 2, 2014 · Fendrix : EPAR - Product Information English (EN) (394. Notifying a change of marketing status. Effortlessly manage View software pricing now at the EMA Store. It introduces the core concepts of PMS, ensuring that all attendees have the chance to understand its implementation. com 3. (This option is located in the left part of the window which is shown in the above image. This product is no longer an orphan medicine. If you do not, you can phone EMA on: Tel. It is intended for patients with inherited mutations affecting a gene known as SMN1, who have either been diagnosed with SMA type 1 (the most severe type) or have up to 3 copies of another gene The EVMPD has been developed by the European Medicines Agency in collaboration with the EudraVigilance implementation fora. 1 products automatically begins after your licensing settings are applied. It can also be used from the age of 18 years and over in adults who are at increased risk of herpes zoster. e. Cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic Human Papillomavirus (HPV) types. Treatment with Zyprexa powder for solution for injection should be discontinued and the use of oral olanzapine should be initiated as The use of this licensing procedure is mandatory for certain types of medicines including: medicines containing a new active substance intended for the treatment of certain conditions (including AIDS, cancer, diabetes and others) advanced-therapy medicines. C. Human Medicines. Myelofibrosis is a disease in which the bone marrow becomes very dense and rigid and produces abnormal, immature blood cells. The EudraGMDP database is the Community database on manufacturing, import and wholesale-distribution authorisations, and good manufacturing-practice (GMP) and good-distribution-practice (GDP) certificates. This notification should be prior to taking any market action, unless, as per paragraph 8. It is also used in adults to treat deep vein thrombosis (blood clot in a deep vein, usually in the leg) and pulmonary embolism (clot in a blood vessel supplying the lungs), and to prevent their In case of impact to EU centrally authorised products, the EMA must also be notified. The license settings you selected are applied and the installation of License Manager begins. sg. Zilbrysq contains the active substance The European Medicines Agency's (EMA) product-specific bioequivalence guidelines outline harmonised regulatory requirements for studies to demonstrate bioequivalence for products that may have Dec 17, 2021 · Prevenar 20 is a vaccine to protect adults and children from 6 weeks of age against pneumonia (infection of the lungs) and invasive diseases (diseases that occur when a bacterium spreads through the body) caused by the bacterium Streptococcus pneumoniae ( S. EMA issues a variety of licences to companies and workers in the electricity and gas industries, companies providing district cooling services to gazetted service areas, and to owners of electrical installations. See sections 4. This can lead to asthma, chronic sinusitis and elevated levels of a type of white blood cell called eosinophils. The installation of your OrCAD/Allegro 22. Xtandi is a cancer medicine used to treat men with prostate cancer. More information can be found under ' Product-information requirements '. With OrCAD, address all your design challenges in a single, unified environment. You can browse a selection of these below, A-Z. Volibris is used in patients with class II or III disease. EMA Design Automation is your full-service provider of CAD software, services, 5-star support, and content you need to drive innovation in your products. Trumenba has been shown to trigger the production of protective levels of antibodies against Neisseria meningitidis group B in two main studies. Nucala is used with other medicines in patients aged 6 years and Zejula is a cancer medicine used in women with advanced ovarian cancer, which includes cancer of the ovaries, fallopian tubes (that connect the ovaries to the uterus) or the peritoneum (the lining around the abdomen). Under the authority of the Emergency Health Services Act, the Board sets licence terms and conditions. Annual fee (level I) €128,100. CUSTOMER STORIES. This includes companies responsible for human medicines and for veterinary medicines, both centrally and nationally authorised. OrCAD X is the OrCAD PCB design solution reimagined for the next generation of design challenges. Dengue disease is a mosquito-borne tropical disease caused by the dengue virus, leading to mild, flu-like symptoms in most people. pneumoniae ). Use - whether the vaccine is for primary or for booster vaccination. It is used as an add-on to asthma treatment in patients from 6 years of age when an antibody called immunoglobulin E (IgE) causes the asthma. Sep 29, 2014 · Eliquis is a medicine used to prevent venous thromboembolism (blood clots in the veins) in adults following a hip or knee replacement operation. The first study involved around 3,600 participants aged 10 to 18 years, and the second study involved around 3,300 young adults between 18 and 25 years of age; none of the participants had previously been vaccinated against N. +31(0)88 781 6000 (EMA switchboard) Tel. 54 KB - PDF) First published: 07/04/2009 Last updated: 24/05/2023 Alkindi : EPAR - Product Information English (EN) (869. For enquiries related to the e-Licensing Information Services (ELISE) portal, please email to ema_rd_elise@ema. €88,900. Importers import and sell electricity to Singapore. Oct 13, 2023 · Elrexfio is a cancer medicine used to treat adults with multiple myeloma (a cancer of the bone marrow) when the cancer has come back (relapsed) and has not responded to treatment (refractory). This is to ensure that proper privacy and security measures are in place and that the principles of integrity, accountability and availability of data are adhered to. Registration is based on the existing The overview below summarises the characteristics of the COVID-19 vaccines authorised in the EU: Platforms - the type of technology used to develop the vaccine. hybrid medicines. The vaccine can be given to adults, adolescents and children from 4 years of age. It was originally designated an orphan medicine on 14 February 2001. For enquiries on the application and renewal of electrical or supply installation licences, please send us an email at ema_lei@ema. For a complete list of scientific guidelines currently open for consultation, see Public consultations. This page lists the timetables for the submission, start and finish dates of procedures, as well as other interim dates and milestones that occur during the various procedures. blood vessel), where they activate several processes including cell division and the growth of new blood vessels. Keytruda is also used in children aged 3 years and older with classical Hodgkin eosinophilic granulomatosis with polyangiitis (EGPA), a disease that causes vasculitis (inflammation of blood vessels) in the lungs, heart, intestines, and nerves. Select a radio option to indicate your system operating system. Seamlessly get your design done on-time, the first-time by leveraging tools built to help you design for peak productivity, accuracy, and speed. g. medicines derived from biotechnology processes. The European Medicines Agency (EMA) works with the European Commission and other EU partners in implementing the Regulation. Each electricity licensee plays a different role to ensure that homes, offices and industries have a competitive, secure and reliable supply of electricity. acute myeloid leukaemia (AML). EMA and FDA biosimilar approvals between 2015 and 2019. 03 MB - PDF) First published: 01/09/2009 Last updated: 07/09/2023 Herceptin is indicated for the treatment of patients with HER2-positive early breast cancer: following surgery, chemotherapy (neoadjuvant or adjuvant) and radiotherapy (if applicable); following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel; in combination with adjuvant chemotherapy Good pharmacovigilance practices (GVP) are a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union (EU). PAH is abnormally high blood pressure in the arteries of the lungs. €42,900. GVP apply to marketing-authorisation holders, the European Medicines Agency (EMA) and medicines regulatory authorities in EU Member States. Corporate. Sep 20, 2023 · Apretude is a medicine used for preventing sexually transmitted HIV-1 infection (pre-exposure prophylaxis or PrEP) in adults and adolescents weighing at least 35 kg who are at high risk of being infected. marketing authorisations for medicinal products which are placed on their markets, except for medicinal products which are authorised under Regulation (EC) No 726/2004 (“Union Authorisations” - see Section 2. Invasive disease occurs when the bacteria spread through the body causing serious infections such as meningitis (infection Therapeutic indication. Verzenios is a cancer medicine used to treat women with breast cancer that is advanced or has spread to other parts of the body (metastatic). A public version of the database has been available since 2011, which allows public Licences. Dupixent is a medicine used to treat: moderate to severe atopic dermatitis (also known as atopic eczema, when the skin is itchy, red and dry) in patients aged 12 years and over when treatments applied to the skin are not sufficient or appropriate. Apretude contains the active substance cabotegravir. The ‘class’ reflects the seriousness of the disease: ‘class II’ involves Jan 28, 2022 · Veterinary product information templates. A generic medicine is developed to be the same as a medicine that has already been authorised, called the reference medicine. In addition, the board investigates complaints and conducts hearings where necessary. Xolair must only be used in patients who: have had many severe asthma attacks (that require rescue treatment with The appointed LEW will submit the electrical installation license application via EMA's e-Licence Information Services (ELISE) portal on behalf of the consumer. The European Medicines Agency's (EMA) provides templates for product information for use by applicants and marketing authorisation holders of veterinary medicines. Duchenne muscular dystrophy is a genetic disease that gradually causes weakness and loss of muscle function. If that option was selected, this may take a few minutes to complete. Adults. For CLL, it is used either in combination with other cancer medicines or on its own. It is used: together with carboplatin and paclitaxel (other cancer medicines, also called chemotherapy) in adults whose cancer is suitable for systemic therapy (treatment that affects the whole body); on its Nov 10, 2023 · Rystiggo is a medicine for treating adults with generalised myasthenia gravis (a disease that leads to muscle weakness and tiredness) and whose immune system produces antibodies against proteins called acetylcholine receptor or muscle-specific tyrosine kinase, which are found on muscle cells. Strains - the type of virus the vaccine targets, i. medicines used for rare human diseases The active substance in Vargatef, nintedanib, blocks the activity of some enzymes known as tyrosine kinases. Nov 15, 2022 · Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Beyfortus have been included in the summary of product characteristics and the package leaflet. It is given together with other medicines used for Yervoy is a cancer medicine used to treat the following: • advanced melanoma (a type of skin cancer) in adults and adolescents from 12 years of age; • advanced renal cell carcinoma (a kidney cancer) in adults; • non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body (metastatic) and has not been treated Product-information requirements. Good manufacturing practice (GMP) describes the minimum standard that a medicines manufacturer must meet in their production processes. 'wild-type' (original), a variant or a sub-variant of the virus. 1 for important information on the data that support this indication. Covers all marketing authorisations relevant in the UK. It Click the Install button. During those inspections, which often take several days, we check whether Jakavi is a medicine used to treat the following conditions: splenomegaly (enlarged spleen) or other disease-related symptoms such as fever, night sweats, bone pain and weight loss in adults who have myelofibrosis. Such an authorisation can be granted in the European Union (EU), via the European Medicines Agency (EMEA), European Commission (EC) and member state's competent authorities or, specifically in the UK, via the Medicines and Healthcare product Regulatory Agency Feb 22, 2024 · If you’re using the Dashboard view, go to the Billing > Your products page. EMA's Working Group on Quality Review of Documents (QRD) develops, reviews and updates these templates. Throughout this challenging period, Christa’s steadfast advocacy, commitment and dedication as chair of EMA’s Management Board was exemplary. Sep 15, 2023 · Zilbrysq is a medicine used to treat generalised myasthenia gravis (a disease that leads to muscle weakness and tiredness) in adults whose immune system produces antibodies against a protein called the acetylcholine receptor. Zyprexa powder for solution for injection is indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia or manic episode, when oral therapy is not appropriate. 3. gov. The European Medicines Agency (EMA) provides guidance and templates to provide marketing authorisation applicants with practical advice on how to draw up the product information for human medicines, which includes the summary of product characteristics, labelling and package leaflet. Click the Install button. Documents providing officially approved information for healthcare professionals and patients on a medicine. Member States shall enter the information relating to the authorisations referred to article 77(4) of the Directive 2001/83/EC as amended, and article 99 of Regulation (EC) 2019/6 into EudraGMDP as referred to in article 111(6) of the Directive 2001/83/EC as EMA Chair coincided with a series of crises and organisational challenges – Brexit, EMA’s move to Amsterdam and the COVID-19 emergency. It can be used on its own for maintenance (continuing) treatment: Ovarian cancer is rare and Zejula was designated an ‘orphan Good distribution practice (GDP) describes the minimum standards that a wholesale distributor must meet to ensure that the quality and integrity of medicines is maintained throughout the supply chain. Benlysta is a medicine used as an add-on treatment in patients aged 5 years and older with systemic lupus erythematosus (SLE), a disease in which the immune system (the body’s natural defences) attacks normal cells and tissues, causing inflammation and organ damage. In order to obtain a national marketing authorisation, an application must be Good manufacturing practice. The European Medicines Agency (EMA) offers training on how to submit and retrieve medicinal product data using the extended EudraVigilance medicinal product dictionary (XEVMPD), also known as Article 57 database. They cover medicines authorised centrally via the Agency The European Medicines Agency's scientific guidelines on the manufacture of medicinal products help medicine developers prepare marketing authorisation applications for human medicines. Patients from 6 months up to 12 years of age can also be given the medicine if their condition is Ofev is a medicine used to treat adults with: idiopathic pulmonary fibrosis (IPF), a disease of unknown cause in which fibrous tissue forms in the lungs; systemic sclerosis associated interstitial lung disease, a disease in which the immune system (the body’s natural defences) is overactive, causing production of fibrous tissue and Qdenga is a vaccine that helps protect against dengue disease. Our officers will respond to you within 3 working days. The Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) updated the rules on the authorisation and use of veterinary medicines in the European Union (EU) when it became applicable on 28 January 2022. The European Medicines Agency (EMA) assesses applications from companies to market generic medicines in the European Union (EU). Oct 16, 2020 · Lenalidomide Mylan is a medicine used for the treatment of certain cancers affecting blood cells, namely multiple myeloma and follicular lymphoma. Commission decisions are published in the Community Register of medicinal products for human use. For information on treatments and vaccines for COVID-19, including Apr 4, 2014 · Nimenrix is a vaccine used to protect adults, adolescents and children from the age of 6 weeks against invasive meningococcal disease caused by four groups of the bacterium Neisseria meningitidis (group A, C, W-135, and Y). This page lists questions relating to the notification of marketing and cessation, suspension, withdrawal of a medicinal product from the market and withdrawal of a marketing authorisation. View Datasheet. 26 of Chapter 8, the need for market action is so serious as to warrant immediate action to protect patient or animal health. full applications, extensions and variations, as well as response timetables). Jul 30, 2015 · Keytruda is a cancer medicine used to treat: gastric cancer, small intestine cancer, biliary cancer. It also covers 'sunset-clause' monitoring. Product Licences - MHRA and EMA. The Dutch Health and Youth Care Inspectorate (IGJ) carries out periodic inspections at all medicinal product manufacturers in the Netherlands. The information contained in these . Generation companies produce electricity, and have at least one generating unit of 10 MW or above each. 2 of this chapter). +31(0)88 781 7676; Outside of EMA business hours, use the following urgent contact Mar 25, 2024 · Wholesale distributors of medicinal products must possess an authorisation to engage in activity as a wholesaler in medicinal products. Mar 27, 2020 · Zolgensma is a gene therapy medicine for treating spinal muscular atrophy, a serious condition of the nerves that causes muscle wasting and weakness. 4 that matches the version of your product licensing. ICH Q8 (R2) Pharmaceutical development. Human Product information. Identifies all product licences granted by the MHRA, as well as all European Medicines Agency licences under the centralised procedure. Menveo is indicated for active immunisation of children (from two years of age), adolescents and adults at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease. To begin data submission on authorised medicines, marketing-authorisation holders need to register with EudraVigilance. EMA publishes a European public assessment report (EPAR) for each medicine. Fees are adjusted every year for inflation. Benlysta is given to patients whose disease is still highly active despite No, EMA will not issue an electrical installation licence for your unit if you do not have a separate electricity account with SP Services for that unit. As such, the EVMPD was designed to support the collection, reporting, coding and evaluation of authorised Dec 21, 2020 · This follows the granting of a conditional marketing authorisation by the European Commission on 21 December 2020. Automatically group and place components based on schematic connectivity, create and apply reuse templates with known-good intellectual property, and accelerate the creation of current and future PCB designs. Xolair is used to improve the control of severe persistent asthma caused by an allergy. These enzymes can be found in certain receptors (such as VEGF, FGF and PDGF receptors) on the surface of cancer cells and on the cells of the surrounding tissue (e. 4 products automatically begins after your licensing settings are applied. Guidelines. Duchenne muscular dystrophy is rare, and Agamree was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 22 August 2014. On the subscription details page, in the Licenses section, select Add more licenses. Figure 3. It is used when the cancer is metastatic (has spread to other parts of the body), castration resistant (worsens despite treatment to lower production of testosterone or after surgical removal of the testes) and when either: treatment with docetaxel (a cancer medicine) has not Dec 22, 2021 · Click Install to download and install your OrCAD and Allegro software products. The event is designed to raise awareness and provide in-depth insights Mar 18, 2019 · If you are uncertain about the classification of your product fill out the ATMP advice form or consult the Reflection paper on classification of advanced therapy medicinal products (EMA/CAT/600280 The EMA approved a record of 16 biosimilars in both 2017 and 2018, with fewer approvals in 2019, while the FDA is growing their biosimilar portfolio at a current, steady pace, yet the overall number of approvals is fewer compared to the EMA’s. 69 KB - PDF) First published: 01/03/2018 Last updated: 31/01/2024 The principles of GMP are defined in law and described in EU Directive 2017/1572/EU and Delegated Regulation (EU) 2017/1569. When a new marketing authorisation application is refused, EMA publishes a refusal EPAR, including a question and answer document and an assessment report. The European Medicines Agency (EMA) coordinates inspections to verify compliance with these standards and plays a key role in harmonising GMP activities at European Union (EU) level. Timetables are categorised according to the type of procedure (e. Several EMA IT systems will be partially or fully inaccessible at different intervals between 11 and 17 April 2024 due to data transfer operations. Experience the future of PCB design with OrCAD. Registration. The product information includes the summary of product characteristics, package leaflet and labelling. Once granted by the European Commission, the centralised marketing authorisation is valid in all European Union (EU) Member States, Iceland, Norway and Liechtenstein. It is given together with other medicines used for treating myasthenia gravis. With massive improvements in performance, productivity, and capability, OrCAD X represents a new era in productivity for designers. It is also used to treat men and women with early breast cancer after surgery where the cancer has spread to the lymph nodes (node-positive) and display other features indicating a higher risk for the From €17,600 to 53,600. Feb 26, 2021 · Jemperli is a cancer medicine for treating certain types of endometrial cancer (cancer of the womb) that are advanced or have come back. 4 and 5. The database provides fast, easy to search and clear reports, to enable product opportunities to be assessed. This content applies to human and veterinary medicines. In addition to all functions which are already included in the standard version, Pro supports the differential signals, interactive routing, constraint management, and Real-Time PCB Design. Invasive disease occurs when the bacteria spread through the body causing serious infections such as meningitis (infection of the membranes that surround the Before a medicinal product* can be marketed in the UK, a marketing authorisation (formerly called a ‘product licence’) is needed. Streamline the PCB layout with the advanced component placement and reuse features of CircuitSpace. Vials. Human Veterinary Corporate Brexit. The European Medicines Agency (EMA) hosts a number of websites and systems to support its work. In multiple myeloma, a cancer of a type of white blood cells called plasma cells, Lenalidomide Mylan is used: in adults with previously untreated (newly diagnosed) multiple myeloma, who have had a Volibris is a medicine that is used alone or combined with other medicines to treat adults with pulmonary arterial hypertension (PAH). , including first responders. -. It should be used in combination with safer sex practices, such as using condoms. Nov 10, 2023 · Overview. In 2022, people began to live with COVID-19 in the community. Each month, the European Medicines Agency's (EMA) publishes an updated list of medicines for human use currently under evaluation by EMA’s Committee for Medicinal Products for Human Use ( CHMP ) to obtain a marketing authorisation in the European Union (EU). A generic medicine contains the same active substance(s) as the reference Jan 9, 2009 · Application form for European Medicines Agency certificates of medicinal products English (EN) (1. Omjjara is a medicine used to treat splenomegaly (enlarged spleen) or other disease-related symptoms in adults who have myelofibrosis and moderate to severe anaemia (low levels of red blood cells). The European Medicines Agency (EMA) and the European Commission have been providing guidance to help pharmaceutical companies prepare for the consequences of Brexit since 2017. Opdivo is a cancer medicine used in adults to treat the following: melanoma, a type of skin cancer; a lung cancer called non-small cell lung cancer (NSCLC); advanced renal cell carcinoma, a kidney cancer; classical Hodgkin lymphoma, a cancer of the lymphocytes (a type of white blood cell); squamous cell cancer of the head and neck (SCCHN); Shingrix is a vaccine used in adults aged 50 years and over to protect against shingles (herpes zoster) and post-herpetic neuralgia (long-lasting nerve pain following shingles). dolgqtbtiydktnhihzop
Scholarships Portal